ADTIGER CORP(01163) releases its interim financial results, with a profit of 1.787 million yuan for the period, turning a loss into a profit compared to the same period last year.

26/08/2025

Tiger Media (01163) released its financial results for the six months ended June 30, 2025, during which the group generated revenue.

ADTIGER CORP (01163) released its performance for the six months ended on June 30, 2025. The group achieved a revenue of 154 million yuan during the period, an increase of 18.1% year-on-year. The group also turned a loss into a profit with a net profit of 1.787 million yuan during the period. Basic earnings per share were 0.2 cents.

AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.

Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.

AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.

Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.